Project Grant HT94252410694
Award Date
7/1/24
Completion Date
6/30/28
Dollars Obligated
$924K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Detroit, MI 48202, USA
Similar Awards
The U.S. Department of Defense's Defense Health Agency awarded a $693,000 Project Grant to Wayne State University in Detroit, Michigan under the Military Medical Research and Development program (CFDA 12.420). The grant supports the university's "EPIGENETIC THERAPEUTIC TARGETING OF ENHANCER HUBS FOR BREAST CANCER" research project, which aims to develop new treatments for breast cancer. The 3-year award, running from December 15, 2023 to December 14, 2026, will fund basic,...
The Department of the Army Medical Command awarded Wayne State University $533,261 under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of July 1, 2022 through June 30, 2025. The award will support the university's project "MNRR1, A Novel Mechanistic Target for Triple-Negative Breast Cancer Metastasis." Through this funding, Wayne State University researchers will investigate medical solutions for triple-negative breast cancer...
Wayne State University was awarded a $538,792 project grant from the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420) to conduct research titled "Targeting TINAGL1 to Enhance Immunotherapy Response in Lung Cancer." The three-year award beginning May 1, 2023 will support the university's efforts to investigate medical solutions for battlefield injuries and transform military and public health care through innovative biomedical research....
Wayne State University was awarded a $1,386,000 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant will fund a novel strategy targeting the metabolic vulnerability of castration-resistant prostate cancer (CRPC) from July 1, 2023 to June 30, 2026. Through this award, Wayne State University researchers will investigate medical solutions for prostate cancer by developing and applying an innovative approach focused on CRPC's...
The Defense Health Agency awarded Wayne State University a $616,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to investigate the molecular mechanisms and therapeutic potential of the RNA methyltransferase FTSJ3 in regulating ribosome biogenesis in liver cancer. The project will be conducted over a 2-year period from September 30, 2023 to September 29, 2025. As a premier public research university, Wayne State University has a track record of...
This $385,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports Wayne State University's research to develop therapeutic approaches targeting spiral ganglion-cochlear nucleus synaptopathy. The two-year award, running from September 1, 2023 to August 31, 2025, aims to transform health care for Service Members and the American public through innovative and impactful biomedical research. As a prominent public...
The Department of the Army Medical Command awarded Wayne State University a $621,739 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research on MNRR1, a novel mechanistic target for triple-negative breast cancer metastasis from July 1, 2022 to June 30, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
This $1,555,176 federal Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) will support the University of Michigan's research on therapeutic modulation of the serine/threonine phosphatase PP2A for the treatment of uterine serous cancer (USC) and uterine carcinosarcoma (UCS). The award, which runs from Aug 2024 to Aug 2027, will enable the University to conduct advanced biomedical research aimed at transforming...
The Department of Defense's Defense Health Agency awarded a $1,127,375 Project Grant to The Washington University Office of Sponsored Research Services Division under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from Sep 30, 2023 to Sep 29, 2027, will fund research on "REPLICATION DRIVEN VULNERABILITIES IN CYCLIN E OVEREXPRESSING OVARIAN CANCERS". As a prominent research institution with expertise in biomedical sciences, The Washington...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $1,555,000.00 to the University of Wisconsin System to conduct research on optimizing equitable ovarian cancer outcomes through population modeling. The 4-year award, effective from April 15, 2025 to April 14, 2029, will support the university's research and development efforts to transform healthcare for military service members...